Results 71 to 80 of about 35,915 (205)

Paucibacillary Pleural Tuberculosis Presenting as Subpleural Nodules: A Diagnostic Challenge With Negative PCR and Smear Tests

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Pleural tuberculosis is a common manifestation of extrapulmonary tuberculosis; however, its diagnosis remains challenging in paucibacillary disease, where clinical presentation may be atypical and microbiological tests frequently yield negative results.
Omar Al Ayoubi, Mohammad Alaa Aldakak, Bassel Ibrahim, Raneem Ahmad, Youness Souleiman   +4 more
wiley   +1 more source

Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs

Acta Medica Martiniana, 2020
Tuberculosis is an airborne infectious disease that remains a huge global health-related issue nowadays. Despite constant approvals of newly developed drugs, the use of first-line antituberculosis medicines seems reasonable in drug-susceptible ...
Prso K, Zidekova N, Dohal M, Porvaznik I, Prso M, Kertys M, Mokry J   +6 more
doaj   +1 more source

Colorimetric methods for rapid determination of pyrazinamide resistance

International Journal of Mycobacteriology, 2020
Background: Because pyrazinamide (PZA) is only effective for Mycobacterium tuberculosis at an acidic pH, susceptibility tests are more difficult to perform than those for other anti-tuberculosis (TB) drugs.
Ahmet Ugur Akbal, Belma Durupinar, Ahmet Yilmaz Coban   +2 more
doaj   +1 more source

Vegetating Lupus Vulgaris in a Child

JEADV Clinical Practice, EarlyView.
Viktor Pushkarenko, Yana‐Karina Zovdun, Olga Pushkarenko   +2 more
wiley   +1 more source

Tuberculosis Presenting as Migratory Arthritis: A Case Report from Iraq

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Extrapulmonary tuberculosis is uncommon, and musculoskeletal involvement presenting as migratory arthritis is particularly rare in immunocompetent individuals, often leading to misdiagnosis and delayed treatment. We report the case of a 66‐year‐old man with diabetes mellitus who presented with recurrent migratory inflammatory arthritis ...
Farah Jaafar Mahdi, Mariam Salem Othman, Ahmed Dheyaa Al‐Obaidi, Mustafa Almusawi, Marafi Jammaa Ahmed, Aya Ahmed Shimal, Elian Khalafalla Awadalla, Marwah Algodi   +7 more
wiley   +1 more source

A four-month gatifloxacin-containing regimen for treating tuberculosis. [PDF]

, 2014
BACKGROUND: Shortening the course of treatment for tuberculosis would be a major improvement for case management and disease control. This phase 3 trial assessed the efficacy and safety of a 4-month gatifloxacin-containing regimen for treating rifampin ...
Amukoye, Evans, Bah, Boubacar, de Jong, Bouke C, Fielding, Katherine, Gninafon, Martin, Horton, John, Kassa, Ferdinand, Lapujade, Olivier, Lienhardt, Christian, Lo, Mame B, Merle, Corinne S, Mthiyane, Thuli, N'Diaye, Alimatou, Odhiambo, Joseph, OFLOTUB/Gatifloxacin for Tuberculosis Project, Olliaro, Piero L, Perronne, Christian, Rustomjee, Roxana, Sismanidis, Charalambos, Sow, Omou Bah   +19 more
core   +1 more source

Dyslipidemia in Pulmonary Tuberculosis Patients Attending Nsawam Adoagyiri Municipal Hospital: Pre‐ and Post‐Anti‐Tuberculosis Treatment

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Tuberculosis (TB) remains a significant public health problem in Ghana, with high morbidity and mortality rates. Persons with TB are at risk of adverse cardiovascular disease with hyperlipidemia being a major risk factor. The standard treatment for pulmonary TB includes a combination of anti‐tuberculosis drugs such as Rifampicin ...
Prince Agyeman, Nixon Ntiri Somuah, Yussif Adams, Felix Abekah Botchway   +3 more
wiley   +1 more source

Drug-Resistant Tuberculosis--Current Dilemmas, Unanswered Questions, Challenges and Priority Needs [PDF]

, 2012
Tuberculosis was declared a global emergency by the World Health Organization (WHO) in 1993. Following the declaration and the promotion in 1995 of directly observed treatment short course (DOTS), a cost-effective strategy to contain the tuberculosis ...
Abubakar, Ibrahim, Atun, Rifat, Chakaya, Jeremiah, Cox, Helen, Ditiu, Lucica, Ford, Nathan, Grobusch, Martin, Hoelscher, Michael, Lawn, Stephen D., Maeurer, Markus, Marais, Ben, Mchugh, Timothy D., McNerney, Ruth, Memish, Ziad, Migliori, Giovanni-Battista, Mwaba, Peter, O'Grady, Justin, Pletschette, Michel, Ramsay, Andrew, Raviglione, Mario, Schito, Marco, Squire, S. Bertel, Swaminathan, Soumya, Zumla, Alimuddin   +23 more
core   +1 more source

Efficacy of Dolutegravir Plus Lamivudine in People With TB/HIV Co‐Infection Using a Rifampicin or Rifabutin‐Based Regimen: A Retrospective Observational Case Series

Immunity, Inflammation and Disease, Volume 14, Issue 3, March 2026.
ABSTRACT Introduction Co‐infection with tuberculosis (TB) is the leading cause of death in individuals infected with human immunodeficiency virus (HIV)‐1. Dolutegravir and lamivudine (DTG + 3TC) has recently been recommended as the preferred first‐line regimen for the treatment of new and treatment‐experienced HIV‐infected patients.
Jinhong He, Xiangxi He, Xiaoxin Xie, Yanhua Fu, Xingxing Luo, Yinshuang Peng, Bin Xu, Hai Long   +7 more
wiley   +1 more source

Combined Oral Contraceptive Drug–Drug Interaction Study With Ganfeborole, a New Anti‐Tuberculosis Agent

The Journal of Clinical Pharmacology, Volume 66, Issue 3, March 2026.
Abstract New drugs are urgently needed to treat drug‐resistant tuberculosis in combination regimens. Ganfeborole demonstrated bactericidal activity and good tolerability in clinical trials. In preclinical studies, ganfeborole showed embryofetal developmental effects, currently mandating highly effective non‐user dependent contraception in women of ...
Laura Iavarone, Silvia M. Lavezzi, Antonio J. Carcas, Tetyana Chaychenko, Raquel Gabarro‐Carrion, Arturo Gómez López de las Huertas, Stephanie Gresham, Alicia Marín‐Candón, Sophie L. Penman, Katie Rolfe, Simon Tiberi, David Barros‐Aguirre, Alberto M. Borobia, the ERA4TB consortium   +13 more
wiley   +1 more source